BNP Paribas Knock-Out EUR/AUD/ DE000PD4N657 /
21/06/2024 21:20:47 | Diferencia+0.080 | Bid21:56:39 | Ask21:56:39 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
6.990EUR | +1.16% | 6.970 Volumen de oferta: 10,000 |
6.990 Tamaño/ Volumen/ Formato de Ask: 10,000 |
- | 1.4974 - | 31/12/2078 | Call |
GlobeNewswire
1:15
Crown Crafts to Announce Fourth Quarter and Full Year Fiscal 2024 Results on June 28, 2024
GlobeNewswire
1:10
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAN, RPHM on Behalf of Shareholders
GlobeNewswire
0:45
Teladoc Health is Providing Free Virtual Health Care Services to New Mexico Residents Impacted by Wi...
GlobeNewswire
0:38
Toyota Announcement: If You Have Suffered Losses in Toyota Motor Corporation (NYSE: TM), You Are Enc...
GlobeNewswire
0:30
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-...
GlobeNewswire
0:24
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against UiPath, Inc. (...
GlobeNewswire
0:00
KIP Protocol Partners with Open Campus to Launch Open Campus U, Transforming Education Through Decen...
GlobeNewswire
21/06
Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest C...
GlobeNewswire
21/06
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against NIKE, Inc. (NK...
GlobeNewswire
21/06
NIKE, INC. (NYSE: NIKE) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Act...
GlobeNewswire
21/06
Metasphere Labs Enters a Definitive Agreement with ARCannabis to Develop VR Virtual Store
GlobeNewswire
21/06
In Major Victory For Injured Owners of “Dangerously Defective” Firearm, Federal Jury Awards $2.35 Mi...
GlobeNewswire
21/06
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página